SD-70

CAS No. 332173-89-4

SD-70( SD70 )

Catalog No. M14117 CAS No. 332173-89-4

A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SD-70
  • Note
    Research use only, not for human use.
  • Brief Description
    A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program.
  • Description
    A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program, in part by inhibition of the demethylase KDM4C (IC50=30 uM); represses AR transcriptional program, increases H3K9me2 levels in 293T cells; inhibits tumor growth in CWR22Rv1 prostate cancer xenograft mice model.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SD70
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    Histone Demethylase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    332173-89-4
  • Formula Weight
    310.353
  • Molecular Formula
    C18H18N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    N-(furan-2-yl(8-hydroxyquinolin-7-yl)methyl)isobutyramide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jin C, et al. Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9235-40.
molnova catalog
related products
  • KDM4C-IN-1

    KDM4C-IN-1 is a selective and potent KDM4C inhibitor (IC50: 8 nM) with potential anticancer activity.KDM4C-IN-1 inhibits the growth of HepG2 and A549 cells, and can be used for the study of leukaemia.

  • NCD-25

    NCD-25 is a novel potent, selective LSD1 inhibitor with IC50 of 0.48 uM.

  • GSK J4 hydrochloride

    GSK J4 HCl is a cell permeable prodrug of GSK J1, which is the first selective inhibitor of the H3K27 histone demethylase JMJD3 and UTX with IC50 of 60 nM.